1. ProMED-mail (2014) MERS-CoV (05): Saudi Arabia, UAE, WHO, RFI.
2. HaagmansBL, Al DhahirySH, ReuskenCB, RajVS, GalianoM, et al. (2013) Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 14: 140–5.
3. PereraRA, WangP, GomaaMR, El-SheshenyR, KandeilA, et al. (2013) Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill 18: pii = 20574.
4. ReuskenCB, HaagmansBL, MullerMA, GutierrezC, GodekeGJ, et al. (2013) Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13: 859–866.
5. BrieseT, MishraN, JainK, ZalmoutIS, JabadoOJ, et al. (2014) Middle East Respiratory Syndrome Coronavirus Quasispecies That Include Homologues of Human Isolates Revealed through Whole-Genome Analysis and Virus Cultured from Dromedary Camels in Saudi Arabia. MBio 5: e01146–14.
6. BarlanA, ZhaoJ, SarkarMK, LiK, McCrayPBJr, et al. (2014) Receptor variation and susceptibility to MERS coronavirus infection. J Virol 88 (9) 4953–61.
7. FalzaranoD, de WitE, RasmussenAL, FeldmannF, OkumuraA, et al. (2013) Treatment with interferon-alpha2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat Med 19: 1313–1317.
8. ColemanCM, MatthewsKL, GoicocheaL, FriemanMB (2013) Wild type and innate immune deficient mice are not susceptible to the Middle East Respiratory Syndrome Coronavirus. J Gen Virol 95 (Pt 2) 408–12.
9. ScobeyT, YountBL, SimsAC, DonaldsonEF, AgnihothramSS, et al. (2013) Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 110: 16157–16162.
10. de WitE, PrescottJ, BaselerL, BushmakerT, ThomasT, et al. (2013) The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS One 8: e69127.
11. RajVS, SmitsSL, ProvaciaLB, van den BrandJM, WiersmaL, et al. (2013) Adenosine Deaminase Acts as a Natural Antagonist for Dipeptidyl Peptidase 4 Mediated Entry of the Middle East Respiratory Syndrome Coronavirus. J Virol 88 (3) 1834–8.
12. ZhaoJ, LiK, Wohlford-LenaneC, AgnihothramSS, FettC, et al. (2014) Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci U S A 111 (13) 4970–5.
13. MunsterVJ, de WitE, FeldmannH (2013) Pneumonia from Human Coronavirus in a Macaque Model. N Engl J Med 368 (16) 1560–2.
14. YaoY, BaoL, DengW, XuL, LiF, et al. (2013) An Animal Model of MERS Produced by Infection of Rhesus Macaques With MERS Coronavirus. J Infect Dis 209 (2) 236–42.
15. de WitE, RasmussenAL, FalzaranoD, BushmakerT, FeldmannF, et al. (2013) Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A 110: 16598–16603.
16. FalzaranoD, de WitE, MartellaroC, CallisonJ, MunsterVJ, et al. (2013) Inhibition of novel beta coronavirus replication by a combination of interferon-alpha2b and ribavirin. Sci Rep 3: 1686.
17. RajVS, MouH, SmitsSL, DekkersDH, MullerMA, et al. (2013) Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495: 251–254.
18. LuG, HuY, WangQ, QiJ, GaoF, et al. (2013) Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500: 227–231.
19. WangN, ShiX, JiangL, ZhangS, WangD, et al. (2013) Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 23: 986–993.
20. van DoremalenN, MiazgowiczKL, Milne-PriceS, BushmakerT, RobertsonS, et al. (2014) Host Species Restriction of Middle East Respiratory Syndrome Coronavirus through its Receptor Dipeptidyl Peptidase 4. J Virol pii: JVI.00676-14 [epub ahead of print].
21. ZakiAM, van BoheemenS, BestebroerTM, OsterhausAD, FouchierRA (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 367: 1814–1820.
22. SchroederC, OsmanAA, RoggenbuckD, MothesT (1999) IgA-gliadin antibodies, IgA-containing circulating immune complexes, and IgA glomerular deposits in wasting marmoset syndrome. Nephrol Dial Transplant 14: 1875–1880.
23. PipesL, LiS, BozinoskiM, PalermoR, PengX, et al. (2013) The non-human primate reference transcriptome resource (NHPRTR) for comparative functional genomics. Nucleic Acids Res 41: D906–914.
24. LauSK, LauCC, ChanKH, LiCP, ChenH, et al. (2013) Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J Gen Virol 94: 2679–2690.
25. SiuKL, YeungML, KokKH, YuenKS, KewC, et al. (2014) Middle East respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in innate antiviral response. J Virol 88 (9) 4866–76.
26. YangX, ChenX, BianG, TuJ, XingY, et al. (2014) Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease. J Gen Virol 95: 614–626.
27. MatthewsKL, ColemanCM, van der MeerY, SnijderEJ, FriemanMB (2014) The ORF4b-encoded accessory proteins of MERS-Coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signaling. J Gen Virol 95 (Pt 4) 874–82.
28. YangY, ZhangL, GengH, DengY, HuangB, et al. (2013) The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 4: 951–961.
29. NiemeyerD, ZillingerT, MuthD, ZieleckiF, HorvathG, et al. (2013) Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J Virol 87: 12489–12495.
30. SeeleyEJ (2013) Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS. Adv Chronic Kidney Dis 20: 14–20.
31. GralinskiLE, BankheadA3rd, JengS, MenacheryVD, ProllS, et al. (2013) Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury. MBio 4: e00271–13.
32. PageC, GoicocheaL, MatthewsK, ZhangY, KloverP, et al. (2012) Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection. J Virol 86: 13334–13349.
33. RockxB, BaasT, ZornetzerGA, HaagmansB, SheahanT, et al. (2009) Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. J Virol 83: 7062–7074.
34. Al-TawfiqJA, MomattinH, DibJ, MemishZA (2014) Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Int J Infect Dis 20: 42–6.
35. LarkinMA, BlackshieldsG, BrownNP, ChennaR, McGettiganPA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
36. PetreyD, XiangZ, TangCL, XieL, GimpelevM, et al. (2003) Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling. Proteins 53 Suppl 6: 430–435.
37. Ponder J (1999) TINKER-software tools for molecular design, version 3.7. Washington University: St. Louis, MO.
38. ZhouH, ZhouY (2002) Distance-scaled, finite ideal-gas reference state improves structure-derived potentials of mean force for structure selection and stability prediction. Protein Sci 11: 2714–2726.
39. CormanVM, EckerleI, BleickerT, ZakiA, LandtO, et al. (2012) Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill 17: 20285.
40. LangmeadB, TrapnellC, PopM, SalzbergSL (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
41. DobinA, DavisCA, SchlesingerF, DrenkowJ, ZaleskiC, et al. (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29: 15–21.
42. McCarthyDJ, ChenY, SmythGK (2012) Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res 40: 4288–4297.